Moreover, to further identify the potential immunotherapy strategy of glioma targeting COL4A factors and HMGA2, immunomodulators associated with COL4A factors and HMGA2 were retrieved from the online database TISIDB (Figure 10; Supplementary Figure S6). The gene discussed is HMGA2; the disease is central nervous system cancer.